Topics

Human medicines European public assessment report (EPAR): Roteas, edoxaban, Stroke,Venous Thromboembolism, Date of authorisation: 19/04/2017, Revision: 3, Status: Authorised

11:40 EST 7 Nov 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Roteas, edoxaban, Stroke,Venous Thromboembolism, Date of authorisation: 19/04/2017, Revision: 3, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Roteas, edoxaban, Stroke,Venous Thromboembolism, Date of authorisation: 19/04/2017, Revision: 3, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Roteas, edoxaban, Stroke,Venous Thromboembolism, Date of authorisation: 19/04/2017, Revision: 3, Status: Authorised"

Quick Search

Relevant Topic

Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...